1. Home
  2. METC vs JANX Comparison

METC vs JANX Comparison

Compare METC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$12.56

Market Cap

994.6M

Sector

Energy

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$14.94

Market Cap

840.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METC
JANX
Founded
2015
2017
Country
United States
United States
Employees
900
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
994.6M
840.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
METC
JANX
Price
$12.56
$14.94
Analyst Decision
Strong Buy
Buy
Analyst Count
8
13
Target Price
$34.00
$47.00
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
$19.61
N/A
Revenue Next Year
$11.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.75
$12.12
52 Week High
$57.80
$35.34

Technical Indicators

Market Signals
Indicator
METC
JANX
Relative Strength Index (RSI) 35.74 55.15
Support Level N/A $13.13
Resistance Level $16.20 $15.49
Average True Range (ATR) 0.92 0.64
MACD -0.32 0.12
Stochastic Oscillator 2.49 61.30

Price Performance

Historical Comparison
METC
JANX

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: